214 related articles for article (PubMed ID: 27530282)
21. Systematic review with meta-analysis: Saccharomyces boulardii for treating acute gastroenteritis in children-a 2020 update.
Szajewska H; Kołodziej M; Zalewski BM
Aliment Pharmacol Ther; 2020 Apr; 51(7):678-688. PubMed ID: 32056266
[TBL] [Abstract][Full Text] [Related]
22. Review article: yeast as probiotics -- Saccharomyces boulardii.
Czerucka D; Piche T; Rampal P
Aliment Pharmacol Ther; 2007 Sep; 26(6):767-78. PubMed ID: 17767461
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness and Safety of Saccharomyces Boulardii for the Treatment of Acute Gastroenteritis in the Pediatric Population: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Fu H; Li J; Xu X; Xia C; Pan Y
Comput Math Methods Med; 2022; 2022():6234858. PubMed ID: 36176742
[TBL] [Abstract][Full Text] [Related]
24. Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children.
Szajewska H; Skórka A; Dylag M
Aliment Pharmacol Ther; 2007 Feb; 25(3):257-64. PubMed ID: 17269987
[TBL] [Abstract][Full Text] [Related]
25. [Saccharomyces boulardii CNCM I-745 - the medicinal yeast improves intestinal enzyme function].
Moré MI
MMW Fortschr Med; 2019 Mar; 161(Suppl 4):20-24. PubMed ID: 30895510
[TBL] [Abstract][Full Text] [Related]
26. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial.
Pozzoni P; Riva A; Bellatorre AG; Amigoni M; Redaelli E; Ronchetti A; Stefani M; Tironi R; Molteni EE; Conte D; Casazza G; Colli A
Am J Gastroenterol; 2012 Jun; 107(6):922-31. PubMed ID: 22472744
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and Safety of Saccharomyces boulardii in Acute Rotavirus Diarrhea: Double Blind Randomized Controlled Trial from a Developing Country.
Das S; Gupta PK; Das RR
J Trop Pediatr; 2016 Dec; 62(6):464-470. PubMed ID: 27283364
[TBL] [Abstract][Full Text] [Related]
28. Use of Probiotics in the Management of Acute Watery Diarrhoea in Nigerian Children: How Effective are S. Boulardii only Preparations?
Amadi OF; Nduagubam OC; Okeke IB; Ndu IK; Ekwochi U; Ogbuka FN
Niger Med J; 2021; 62(2):54-59. PubMed ID: 38505569
[TBL] [Abstract][Full Text] [Related]
29. The Use of Probiotic with ORS and ORS Only in Children with Acute Diarrhea.
Ali R
J Coll Physicians Surg Pak; 2019 Dec; 29(12):1179-1182. PubMed ID: 31839091
[TBL] [Abstract][Full Text] [Related]
30. Saccharomyces boulardii in childhood.
Vandenplas Y; Brunser O; Szajewska H
Eur J Pediatr; 2009 Mar; 168(3):253-65. PubMed ID: 19096876
[TBL] [Abstract][Full Text] [Related]
31. [A prospective control study of
Zhang DM; Xu BB; Yu L; Zheng LF; Chen LP; Wang W
Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):398-401. PubMed ID: 28592037
[No Abstract] [Full Text] [Related]
32. Probiotics for children with diarrhea: an update.
Guandalini S
J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S53-7. PubMed ID: 18520336
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Two Forms of Loperamide-Simeticone and a Probiotic Yeast (Saccharomyces boulardii) in the Treatment of Acute Diarrhoea in Adults: A Randomised Non-Inferiority Clinical Trial.
Cottrell J; Koenig K; Perfekt R; Hofmann R;
Drugs R D; 2015 Dec; 15(4):363-73. PubMed ID: 26541878
[TBL] [Abstract][Full Text] [Related]
34. [A multicentric study of a lactose free formula supplemented with Saccharomyces boulardii in children with acute diarrhea].
Le Luyer B; Makhoul G; Duhamel JF
Arch Pediatr; 2010 May; 17(5):459-65. PubMed ID: 20236813
[TBL] [Abstract][Full Text] [Related]
35. Use of VSL[sharp]3 in the treatment of rotavirus diarrhea in children: preliminary results.
Dubey AP; Rajeshwari K; Chakravarty A; Famularo G
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S126-9. PubMed ID: 18806703
[TBL] [Abstract][Full Text] [Related]
36. Effect of
Ghosh A; Sundaram B; Bhattacharya P; Mohanty N; Dheivamani N; Mane S; Acharyya B; Kamale V; Poddar S; Khobragade A; Thomas W; Prabhudesai S; Choudhary A; Mitra M
Pediatr Gastroenterol Hepatol Nutr; 2021 Sep; 24(5):423-431. PubMed ID: 34557395
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology of Saccharomyces fungemia: A systematic review.
Vinayagamoorthy K; Pentapati KC; Prakash H
Med Mycol; 2023 Feb; 61(2):. PubMed ID: 36806741
[TBL] [Abstract][Full Text] [Related]
38. [Effect of probiotic Saccharomyces boulardii on prevention of antibiotic-associated diarrhea in adult outpatients with amoxicillin treatment].
Bravo MV; Bunout D; Leiva L; de la Maza MP; Barrera G; de la Maza J; Hirsch S
Rev Med Chil; 2008 Aug; 136(8):981-8. PubMed ID: 18949181
[TBL] [Abstract][Full Text] [Related]
39. Bacillus clausii UBBC-07 reduces severity of diarrhoea in children under 5 years of age: a double blind placebo controlled study.
Sudha MR; Jayanthi N; Pandey DC; Verma AK
Benef Microbes; 2019 Mar; 10(2):149-154. PubMed ID: 30638396
[TBL] [Abstract][Full Text] [Related]
40. Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases.
Kaźmierczak-Siedlecka K; Ruszkowski J; Fic M; Folwarski M; Makarewicz W
Curr Microbiol; 2020 Sep; 77(9):1987-1996. PubMed ID: 32472262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
